Edmonton, Canada

Pierre Giguere

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Kronos Bio, Inc.. Active years: 2022-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pierre Giguere. Retrieved from https://idiyas.com/inventor/pierre-giguere-b2g9kx71

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2022-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Pierre Giguere: Innovator in Pharmaceutical Chemistry

Introduction

Pierre Giguere is a notable inventor based in Edmonton, Canada. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of Syk inhibitors. With a total of 2 patents to his name, Giguere's work is recognized for its innovative approach to drug formulation.

Latest Patents

Giguere's latest patents include the crystalline succinate salt of 6-(6-aminopyrazin-2-yl)-N-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidazo[1,2-a]pyrazin-8-amine as a Syk inhibitor. These patents detail the solid forms of the compound and the processes for making these solid forms, along with methods of use. His work emphasizes the importance of characterizing these compounds to enhance their efficacy in therapeutic applications.

Career Highlights

Pierre Giguere is currently employed at Kronos Bio, Inc., where he continues to push the boundaries of pharmaceutical research. His innovative spirit and dedication to advancing drug development have made him a valuable asset to his team and the industry.

Collaborations

Some of Giguere's notable coworkers include Patricia Andres and Peter C Fung. Their collaborative efforts contribute to the dynamic research environment at Kronos Bio, Inc.

Conclusion

Pierre Giguere's contributions to pharmaceutical chemistry through his patents and work at Kronos Bio, Inc. highlight his role as an influential inventor in the field. His innovative approaches to drug formulation continue to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…